Filing Details

Accession Number:
0001562180-21-007868
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-12-22 21:51:47
Reporting Period:
2021-12-20
Accepted Time:
2021-12-22 21:51:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1689813 Biohaven Pharmaceutical Holding Co Ltd. BHVN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1878290 C. George Clark C/O Biohaven Pharmaceuticals, Inc.
215 Church Street
New Haven CT 06510
Vp, Chief Accounting Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2021-12-20 1,915 $123.84 8,240 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.